Immunopotentiating complexes comprising TraT proteins

Details Immunopotentiating complexes comprising TraT proteins Immunopotentiating complexes comprising TraT proteins

1995-06-05

1999-02-23

Sidberry, Hazel F.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4241801, 4241921, 42419711, 435 691, 435 697, 530402, 530403, A61K 39385, A61K 39295, A61K 3940, A61K 3942

Patent

active

058740830

ABSTRACT:
Class of carrier molecules which when covalently linked to an immunogen enhances the host's immune response to that immunogen regardless of whether the complex of carrier and immunogen is administered parenterally, enterally, or orally to the host. In addition, processes are provided for production of the complexes, as well as hybrid DNA sequences encoding complexes, recombinant DNA molecules bearing the hybrid DNA sequences, transformant hosts and vaccines comprising the complexes as well as methods for production of the vaccine.

REFERENCES:
patent: 4336336 (1982-06-01), Silhavy et al.
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4459286 (1984-07-01), Hilleman et al.
patent: 4484923 (1984-11-01), Amkraut et al.
patent: 4578269 (1986-03-01), Morein
Derwent, Abstract Accession No. 86-176377/27.
G. Jung et al., "Potent B-lymphocyte Mitogens as Covalently Bound Carriers for the Presentation of Antigens and the Enhancement of Immune Response", Chemical Abstracts vol. 106, No. 1, Jan. 5, 1987, Abstract No. 3546a.
F. Zavala et al., "Rationale For Development of Synthetic Vaccine Against Plasmodium Falciparum Malaria", Science, vol. 228, Jun. 21, 1985, pp. 1436-1440.
B. Lugtenberg, "Purification of Escherichia coli OmpA Protein", Chemical Abstracts, vol. 105, No. 1, Jul. 7, 1986, p. 302, Abstract No. 3099m.
E. Minkley et al. "Overproduction Purification and Characterization of the F traT Protein", Chemical Abstracts, vol. 101, No. 21, Nov. 19, 1984, p. 170, Abstract No. 184976f.
G. Layton et al.,"The Effects of Oral and Combined Parenteral-Oral Immunization Against an Experimental Escherichia Coli Urinary Tract Infection in Mice",Biological Abstacts,vol. 77,No. 7, 1984, Abs. 541458.
U.K. Laemmli, "Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4", Nature, 227, (1970), 680-685.
I.E. Salit et al., "Intra-Strain Heterogencity of Gonococcal Pili is Related to Opacity Colony Variance" J. Exp. Med. 151, (1980), 716-725.
C.M. Tsai et al. "A Sentitive Silver Starin for Detecting Lipopolysaccharides in Polyacrylamides Gels", Analytical Biochemistry, 119, (1982), 115-119.
Little et al, "Preparation of Immunogenic 2.4 dinitrophnyl & 2.46 Trinitrophenyl Proteins", Methods in Immunology & Immunochemistry, ed. C. Williams et al. Academic Press, New York, (1967), pp. 128-133.
S. Avrameas et al. "Coupling of a Enzymes to Antibodies and Antigens", Scand. J. Immunol., 8, Suppl. 7, (1978), pp. 7-23.
G. Russell-Jones et al. "Identification of Protein Antigens of Group B Streptococci with Special Reference to the 1bc Antigens", J. Exp. Med. 160, (1984), pp. 1476-1484.
R. Ogata et al."Nucleotide Sequence Analysis of the Complement Resistance Gene from Plasmid R100" J. Bacteriol., 151, 2, (1982), pp. 819-827.
M. Dyall-Smith et al. "Antigenic Determinants Coded by Rotavirus Genes", Infectious Diarrhoea in the Young, ed. TZIPORI, Elsevier Publishers, (1985), pp. 215-220.
C. Joyce et al. "Construction of a Plasmid that Over Produces the Large Proteolytic Fragment (Klenow Fragment)of DNA Polymerase 1 of Escherichia coli", Proc. Natl. Acad. Sci. USA, 80, (1983), pp. 1830-1834.
J. Mott et al. "Maximizing Gene Expression from Plasmid Vectors Containing the .lambda. P.sub.L Promoter: Strategies for Over Producing Transcription Termination Factors .rho.", Proc. Natl. Acad. Sci., USA, 82, (1985) pp. 88-92.
C. Marcahl et al. "Un Systeme de Vecteurs Destine a Permette L'Excretion D'Une Proteine Determinee Par Un Gene Clone", C.R. Acad. Sc. Paris , V. 288, Part D, pp. 275-277 (Jan. 15, 1979).
Freudl et al. "Cell Surface Exposure of the Outer Membrane Protein OmpA of Eschericha coli K-12", Chemical Abstracts, vol. 105, No. 1, p. 306, Ref. No. 3151X and J. Mol. Biol. 188(3): pp. 491-494 (1986).
E. Minkley, Jr. "Purification and Characterization of pro-TraTp: The Signal Sequence-Containing Precursor of a Secreted Protein encoded by the F Sex Factor", Chemical Abstracts, vol. 101, No. 3, Jul. 16, 1984, p. 158, Ref. No. 18263b, and J. Bacteriol. 158(2) :464-73 (1984).
A. Chatbit et al. "Probing the Topology of a Bacterial Membrane Protein by Genetic Insertion of a Foreign Epitope: Expression at the Cell Surface", The Embo Journal, vol. 5, No. 11, pp. 3029-3037, IRL Press Ltd., Oxford, UK (Nov. 1986).
Melchers et al. "The Lipoprotein of the Outer Membrane of Escherichis coli; A B-lymphocyte Mitogen", The Journal of Experimental Medicine 142:473 (1975).
Bessler et al. "Induction of Lymphocyte Proliferation and Membrane Changes by Lipopeptide Derivatives of the Lipoprotein from the Outer Membrane of Escherichia coli", Z. Immun, Forsch 153:11 (1977).
Bessler et al. "Protein I and Protein II from the Outer Membrane of Escherichia coli are B-lymphocyte Mitogens", Z. Immun, Forsch 155:387 (1987).
Zollinger et al. "Enhancement of Immunologic Activity by Noncovalent Complexing of Meningococcal Group B Polysaccharide and Outer Membrane Proteins", Seminars in Infectious Diseases, vol. 4, Bacterial Vaccines, (Robbins JB Hill) Chapter 35, p. 254 (1980).
Bessler et al. "The Mitogenic Principle of Escherichia coli Lipoprotein: B-Lymphocyte Mitogenicity of the Synthetic Analouge Palmitoyl-Tetrapeptide", Biochemical and Biophysical Research Communications 121:55 (1984).
Jung et al., "Increased Production of Specific Antibodies by Presentation of the Antigen Determinants with Covalently Coupled Lipopeptide Mitogens", Angew. Chem. Int. Ed. Engl. 24 , p. 872, (1985).
Bessler et al. "Specific Antibodies Elicited by Antigen Covalently Linked to a Synthetic Adjuvant", Immunobiol. 170, 239, (1985).
Bessler et al. "Synthetic Lipopetide Analogs of Bacterial Lipoprotein are Potent Polyclonal Activators C. for Murine B-Lymphocytes", The Journal of Immunology 135, 1900 (1985).
Vordermeier et al. "A Defined Fragment of Bacterial Protein I (Ompf) as a Polyclonal B-Cell Activator", Infection and Immunity 51, 233 (1986).
Bessler et al. "B-Lymphocyte Mitogenicity In Vitro of a Synthetic Lipopeptide Fragment Derived from Bacterial Lipoprotein", Z. Physiol. Chem Bd. 363 S. pp. 767-770, Jul. 1982.
Johnson et al. "Synthetic Analogues of the N-Terminal Lipid Part of Bacterial Lipoprotein are B-Lymphocytes Mitogens In Vitro and In Vivo", Immunobiol. vol. 165, pp. 27-35 (1983).
Supplement European Search Report.
Wetzler et al. J. Exp. Med. 168: pp. 1883-1897 (1988).
Perumal et al, J. of Biol Chem. 259:5357-5360 1984, "The Product of the F. Sex Factor TraT Surface Exclusion Gene is a Lipoprotein" (Abstract Only).
Palva FEMS Symp. "Regulation of Outer Membrane Proteins" vol. 25, 31-37 1985.
Benz et al Crit. Rev Biochem 19:145-190, 1985 "Porin From Bacterial & Mitochondrial Outer Membranes".
Bessler et al Immunobiol. 170:239-244 1985 "Specific Antibodies Elicited by Antigen Covalently Linked to a Synthetic Adjuvant".
Avrameus et al, Scand J. Immol vol. 8 7:7-23, 1978 Coupling of Enzymes to Antibodies & Antigens.
Staros et al Analytical Biochem 156:220-222 1986. Enhancement of N-Hydroxysulfosuccininido of Water Soluble Carbodiimide Medial Coupling Reactions.
Makela et al Seminars in Infectious Disease vol IV Bacterial Vaccines 1982 pp. 360-365, "Porins: The Major Outer Membrane Proteins of Enteric Bacteria on Protective Antigens".
Hoffman et al Science 237:639-642, 1987.
Brown et al, Vaccine 12:102-108, 1994 Safety, Immunogenicity and United Efficacy Study of a Recombinant Plasmodium Falciparium Circumsponorate Vaccine in Thai Soldiers.
Riley Immunology Today 13:127-130, 1992 See pp. 129-130.
Henning et al. Eur. J. Biochem 136:233-240, 1983.
Jung et al Angew Chem Int Ed Engl. 24:872-873, 1985.
Silhavy et al, J. Cell. Biochem Suppl 7B Abstract 332.
Nagahari et al EMBO J. 4 (13A):3589-3592 1985 (Abstract Only).
Svenson et al, Infection & Immunity 25:863-872, 1979.
Becker et al FEBS Lett. 204:145-150, 1986.
Nickardo et al Biochemical & Biophysical Res. Communications 76:324-330, 1977.
Osborn et al Ann Rev Microbiol 34:369-422, 1980.
Henning et al Eur J. Biochem 136:233-240, 1983.
Barbero et al J. Biotechnol 4 255-268, 1986.
Bessler et al Z. Immun-Forsch 155 387-398, 1979.
Takahara et al J. Biol Chem 260:2670-2674, 1985.
Chang

Affiliated with

Also associated with

Rating

Immunopotentiating complexes comprising TraT proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunopotentiating complexes comprising TraT proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunopotentiating complexes comprising TraT proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-304186